<SEC-DOCUMENT>0001606498-25-000057.txt : 20250317
<SEC-HEADER>0001606498-25-000057.hdr.sgml : 20250317
<ACCEPTANCE-DATETIME>20250317073312
ACCESSION NUMBER:		0001606498-25-000057
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		17
CONFORMED PERIOD OF REPORT:	20250314
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20250317
DATE AS OF CHANGE:		20250317

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AVANOS MEDICAL, INC.
		CENTRAL INDEX KEY:			0001606498
		STANDARD INDUSTRIAL CLASSIFICATION:	ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		IRS NUMBER:				464987888
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36440
		FILM NUMBER:		25742358

	BUSINESS ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004
		BUSINESS PHONE:		844-428-2667

	MAIL ADDRESS:	
		STREET 1:		5405 WINDWARD PARKWAY
		STREET 2:		SUITE 100 SOUTH
		CITY:			ALPHARETTA
		STATE:			GA
		ZIP:			30004

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Avanos Medical, Inc.
		DATE OF NAME CHANGE:	20180702

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Halyard Health, Inc.
		DATE OF NAME CHANGE:	20140424
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>avns-20250314.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:010ac6d6-ca10-4749-8791-fbf067c5aa98,g:27a292ec-0cea-45d2-b08f-f668e2e63864,d:b589ecd8bcca4fc6a4350fa9fd49810f-->
<html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>avns-20250314</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-22">0001606498</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-23">false</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-24">March 14, 2025</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="avns-20250314.xsd"/></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001606498</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2025-03-14</xbrli:startDate><xbrli:endDate>2025-03-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ib589ecd8bcca4fc6a4350fa9fd49810f_1"></div><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, D.C. 20549</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:16pt;font-weight:400;line-height:120%">&#160;</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CURRENT REPORT</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported):</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> <ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">March 14, 2025</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><img src="avns-20250314_g1.jpg" alt="avanoslogo.jpg" style="height:34px;margin-bottom:5pt;vertical-align:text-bottom;width:213px"/></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">AVANOS MEDICAL, INC.</ix:nonNumeric> </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.035%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:31.454%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.681%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.432%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.697%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.739%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:31.604%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-36440</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">46-4987888</ix:nonNumeric></span></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(State or other jurisdiction of incorporation)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Commission file number)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(I.R.S. Employer Identification No.)</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">5405 Windward Parkway</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine2" id="f-8">Suite 100 South</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-9">Alpharetta,</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-10">Georgia</ix:nonNumeric></span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-11">30004</ix:nonNumeric></span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="9" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Address of principal executive offices)</span></td><td colspan="6" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">(Zip code)</span></td><td colspan="3" style="padding:0 1pt"/></tr></table></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code: (<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-12">844</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-13">428-2667</ix:nonNumeric></span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.853%"><tr><td style="width:1.0%"/><td style="width:2.853%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:94.947%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-17">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:35.157%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.385%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.158%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-18">Common Stock - $0.01 Par Value</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-19">AVNS</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-20">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-21">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.  </span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="ib589ecd8bcca4fc6a4350fa9fd49810f_7"></div><div style="margin-top:6pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 5.02&#160;&#160;&#160;&#160;Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2025, Avanos Medical, Inc. (the &#8220;Company&#8221;) announced the appointment of David Pacitti as the Company&#8217;s Chief Executive Officer, effective April 14, 2025.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Pacitti, age 59, will join the Company from Siemens Healthineers, a healthcare technology company, where he has served as President and Head of the Americas since February 2018. From October 2015 to February 2018, he served as President and Head of Healthcare, North America for Siemens Healthineers. Prior to that, he held several leadership roles at Abbott Vascular, including Division Vice President of U.S. Commercial Operations, Sales and Marketing and Vice President of Global Marketing. Mr. Pacitti joined Abbott Vascular upon its acquisition of Guidant Corporation, where he served in positions of increasing responsibility from 1995 to 2006. Mr. Pacitti is a former offensive lineman for the Miami Dolphins. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 14, 2025, Mr. Pacitti and the Company entered into an offer letter pursuant to which he will receive a base salary of $1,050,000 per year. In addition, he will be eligible to participate in the Company&#8217;s annual cash incentive program with a bonus target of 110% of his base salary and will be eligible for annual long-term incentive grants under the Company&#8217;s Long Term Incentive Plan with a target award value for 2026 of $5,000,000. In lieu of a 2025 long-term incentive award, Mr. Pacitti will receive a one-time equity award of performance-based restricted share units (&#8220;PRSUs&#8221;) with an award value equal to $3,500,000. Such PRSUs will vest on the third anniversary of the grant date (the &#8220;PRSU Vesting Date&#8221;) and will pay out: (i) at 50% of the number of PRSUs if the price of the Company&#8217;s common stock on the PRSU Vesting Date is $20.00; (ii) at 100% of the number of PRSUs if the price of the Company&#8217;s common stock on the PRSU Vesting Date is $25.00; (iii) at 200% of the number of PRSUs if the price of the Company&#8217;s common stock on the PRSU Vesting Date is $29.00; and (iv) at 250% of the number of PRSUs if the price of the Company&#8217;s common stock on the PRSU Vesting Date is $33.00 or higher. In addition, Mr. Pacitti will receive a one-time equity award of time-based restricted share units (&#8220;TRSUs&#8221;) with an award value equal to $3,500,000. Such TRSUs will vest 30% on the first anniversary of the grant date, 30% on the second anniversary of the grant date and 40% on the third anniversary of the grant date. Finally, Mr. Pacitti will receive a one-time $500,000 cash payment within 30 days of his start date. Mr. Pacitti will be eligible to participate in the standard employee benefit plans generally available to the Company&#8217;s executive employees, including medical, dental, vision and life insurance; flexible spending accounts; Company-paid disability programs; and a matching 401(k) plan. He will also be eligible to participate in the Company&#8217;s Executive Severance Plan, Severance Pay Plan and Executive Level Relocation Program. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The foregoing description of Mr. Pacitti&#8217;s offer letter does not purport to be complete and is qualified in its entirety by reference to the full text of the offer letter, which is filed as Exhibit 10.1 to this Current Report on Form 8-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Pacitti was not selected pursuant to any arrangement or understanding between him and any other person, and he has no family relationships with any of the Company&#8217;s directors or executive officers. There have been no related person transactions between the Company and Mr. Pacitti reportable under Item 404(a) of Regulation S-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending the commencement of Mr. Pacitti&#8217;s service as Chief Executive Officer, the Company expects that Michael C. Greiner will continue to serve as the Company&#8217;s Interim Chief Executive Officer.</span></div><div id="ib589ecd8bcca4fc6a4350fa9fd49810f_152"></div><div style="margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 7.01&#160;&#160;&#160;&#160;Regulation FD Disclosure</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 17, 2025, the Company issued a press release announcing Mr. Pacitti&#8217;s appointment as the Company&#8217;s Chief Executive Officer, effective April 14, 2025. A copy of such press release is attached as Exhibit 99.1 hereto and is incorporated by reference herein in its entirety. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The information contained in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that Section. The information in Item 7.01 of this Current Report on Form 8-K shall not be incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, except as otherwise expressly stated in such filing.</span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt"><span><br/></span></div><div id="ib589ecd8bcca4fc6a4350fa9fd49810f_10"></div><div style="-sec-extract:summary;margin-top:12pt;padding-left:54pt;text-indent:-54pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01&#160;&#160;&#160;&#160;Financial Statements and Exhibits</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">Exhibits.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The following exhibits are filed with this Current Report on Form 8-K:</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:7.844%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.533%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:89.223%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101_offerxletter.htm">10.1*</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="ex101_offerxletter.htm">Offer letter dated March 14, 2025, by and between Avanos Medical, Inc. and David Pacitti</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="avns03142025form8k_ex991.htm">99.1</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="avns03142025form8k_ex991.htm">Press release issued by Avanos Medical, Inc. on March 17, 2025 (furnished only)</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the inline XBRL document)</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*  Management contracts, compensatory plans or arrangements</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div><div id="ib589ecd8bcca4fc6a4350fa9fd49810f_13"></div><hr style="page-break-after:always"/><div style="min-height:42.75pt;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">SIGNATURE</span></div><div style="margin-top:6pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.707%"><tr><td style="width:1.0%"/><td style="width:4.325%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.814%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:40.542%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.005%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:28.814%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">AVANOS MEDICAL, INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Date:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">March 17, 2025</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">By:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ Mojirade James</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mojirade James<br/>Senior Vice President and General Counsel</span></td></tr></table></div><div style="margin-top:6pt"><span><br/></span></div><div style="height:42.75pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>ex101_offerxletter.htm
<DESCRIPTION>EXHIBIT 10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="i527c171ef49b4c318cebc1c3b9c8627b_36"></div><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">March 14, 2025</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Mr. David Pacitti</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Dear Dave,</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We are pleased to extend to you an offer of employment to join Avanos in the position of Chief Executive Officer.  In this role, you will report to the Board of Directors. </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Start Date</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Your anticipated start date is April 14, 2025.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Base Salary</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Your starting salary will be $1,050,000 per year and is subject to applicable withholding and deductions. Consistent with our practices for salaried officers, you will be paid monthly on the last working day of the month.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Short-Term Incentive Compensation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You will be eligible to participate in Avanos&#8217;s annual cash incentive program.  Your bonus incentive target will be 110% of your base pay earned during the year. Bonus criteria are established each year by the Compensation Committee. For 2025, your bonus will be based on Avanos&#8217;s performance for the year against targets previously established by the Compensation Committee. In early 2026, the Compensation Committee will assess the extent to which those performance targets have been met and then approve the resulting payout to executive officers. A description of the annual cash incentive program is set forth in Avanos&#8217;s proxy statement.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Long-Term Incentive Compensation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Beginning in 2026, you will be eligible for annual long-term incentive grants under Avanos&#8217;s Long Term Incentive Plan. Your target award value is $5,000,000. The mix of long-term incentive vehicles and their overall design will be determined by the Compensation Committee in their discretion.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Future annual long-term incentive target grant amounts, along with the grant type and mix, are subject to change by the Compensation Committee in their discretion. The complete terms and conditions of Avanos&#8217;s Long Term Incentive Plan are set forth in Avanos&#8217;s plan document.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Sign-on Awards</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In lieu of your 2025 annual long-term equity award, you will receive a one-time equity award under Avanos&#8217;s Long Term Incentive Plan with an aggregate award value of $7,000,000, determined as of the date you sign this offer letter. Your award will consist of performance share units and restricted share units, as described below.  These awards will be granted on your start date, but the number of shares subject to the awards will be determined based on the closing price of Avanos stock as of the date you sign this offer letter. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:13.8pt">The target number of performance-based restricted share units to be granted will be equal to an award value of $3,500,000, divided by the closing stock price for Avanos shares on </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">the date you sign this offer letter. The performance-based restricted share units will cliff vest at the end of the three-year performance period ending on the third anniversary of the grant date, conditioned upon your continued employment and Avanos&#8217;s achievement of share price appreciation targets during the performance period, as follows&#58; 50% of target at a stock price of $20.00, 100% of target at a stock price of $25.00, 200% of target at a stock price of $29.00, and 250% of target at a stock price of $33.00. In order to vest at any particular level, the stock price must be at or above the relevant price for 20 consecutive trading days during the performance period. </font></div><div><font><br></font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:400;line-height:112%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%;padding-left:12.03pt">The number of restricted share units to be granted will be equal to an award value of $3,500,000, divided by the closing stock price for Avanos shares on the date you sign this offer letter. The restricted share units will vest over a three-year period from your start date (30% on the first anniversary of the grant date, 30% on the second anniversary of the grant date, and 40% on the third anniversary of the grant date), conditioned upon your continued employment&#59; provided, that if you are terminated without Cause (as defined in Avanos&#8217;s Long Term Incentive Plan), your restricted share units will vest in full.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In addition, you will also receive a one-time cash award with an aggregate value of $500,000, which will be paid within thirty days of your start date. In the unlikely event that you voluntarily leave your employment with Avanos before the one year anniversary of your start date, you will be obligated to repay this cash award to Avanos.  </font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Benefits</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Avanos offers a comprehensive benefits package that includes medical, dental, vision, life insurance, flexible spending accounts, company-paid disability programs and a matching 401(k) plan. You will be provided a benefits guide with details of these programs.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Vacation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">As an employee of Avanos, you will receive four (4) weeks of vacation and four (4) personal holidays per year. Vacation and personal holidays are prorated based on your date of hire.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Relocation</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You will be eligible to participate in Avanos&#8217;s Executive Level Relocation Program. Weichert Workforce Mobility Inc. administers Avanos&#8217;s relocation services. A Weichert representative will contact you following your acceptance of this employment offer to review the Relocation Program with you.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">In the unlikely event that you voluntarily leave the organization before the second anniversary of your start date, you will be obligated to repay to Avanos any relocation payments you have received under the Relocation Program.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Severance</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You will be eligible to participate in Avanos&#8217;s existing Severance Pay Plan and Executive Severance Plan. The general terms of those plans are described in Avanos&#8217;s proxy statement, and the complete terms and conditions are set forth in Avanos&#8217;s plan documents.</font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:112%">Other Considerations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">This offer is contingent upon&#58; (1) the satisfactory completion of a background check and drug test&#59; (2) verification of your legal right to work in the United States&#59; (3) acknowledgment that you are not under any non-compete, non-solicitation or any other agreements that would prevent you from working for Avanos&#59; and (4) your acceptance of Avanos&#8217;s Confidentiality, Non-Solicitation and Assignment of Business Ideas Agreement. This agreement is required of all new hires of Avanos because of an employee's potential access to confidential information, customer lists and trade secrets.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Employment at Avanos is at-will and can be ended by you or the Company for any reason at any time. Furthermore, this letter is simply intended to provide a general description of the terms of your at-will employment. It does not constitute a contract or give rise to any contractual or quasi-contractual rights, and the offer of employment or the terms of the employment may be changed or rescinded by Avanos at any time.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">You will be an executive officer of Avanos and as such you will have obligations to file reports under Section 16 of the Securities and Exchange Act of 1934. The Company has a compliance program to assist officers and board members to meet their Section 16 filing obligations. In order to file Section16 reports required as a result of your hiring (a Form 3) and your receipt of the equity grants referenced above (a Form 4), the Company will need you to provide it with your SEC filing codes as soon as possible. Your Form 4 will be due no later than 2 days following the grant date of your awards.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">We look forward to your acceptance of this offer and would appreciate your prompt response.  If you have any questions or need additional information, please give me a call.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Sincerely,</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.467%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Gary Blackford</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Gary Blackford, Chairman</font></td></tr></table></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">To indicate your acceptance of this offer and its terms and conditions, please sign in the space provided below.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:112%">Accepted&#58;</font></div><div><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.467%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; David Pacitti</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">March 14, 2025</font></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date</font></td></tr></table></div><div><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>3
<FILENAME>avns03142025form8k_ex991.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2025 Workiva -->
<title>Document</title></head><body><div id="ib91dcb16640a458b86b27ad2b7d005ad_1"></div><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.132%"><tr><td style="width:1.0%"></td><td style="width:29.353%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:37.992%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:29.355%"></td><td style="width:0.1%"></td></tr><tr style="height:65pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"><div style="text-align:center"><img alt="avanoslogoa08.jpg" src="avanoslogoa08.jpg" style="height:42px;margin-bottom:5pt;vertical-align:text-bottom;width:262px"></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:94.396%"><tr><td style="width:1.0%"></td><td style="width:54.151%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.880%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.669%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Media Contact&#58; Katrine Kubis</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Avanos Medical, Inc.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">CorporateCommunications&#64;Avanos.com</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Avanos Medical Announces Appointment of David Pacitti as Chief Executive Officer</font></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.275%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:5pt"><td colspan="3" style="border-bottom:2pt solid #000000;padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">ALPHARETTA, Ga., March 17, 2025&#47;PRNewswire&#47; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">-- Avanos Medical, Inc. (NYSE&#58; AVNS), a leading medical technology company, today announced the appointment of David Pacitti as its new chief executive officer, effective April 14, 2025. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pacitti joins Avanos with a distinguished career in the healthcare sector, most recently serving as president of Siemens Medical Solutions USA, Inc. and Head of the Americas, Siemens Healthineers. In this capacity, he played a pivotal role in driving strategic growth and operational excellence while leading the marketing, sales, service, and support functions in North America and Latin America across the entire Siemens Healthineers portfolio, including medical imaging, laboratory diagnostics, therapy solutions, and services.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;We are delighted to welcome David Pacitti as the new CEO of Avanos Medical,&#8221; said Gary Blackford, chair of the Avanos board of directors. &#8220;David&#8217;s extensive industry expertise, leadership acumen, and strategic vision make him the ideal choice to lead Avanos in its next phase of growth and success.&#8221;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Prior to joining Siemens Healthineers in 2015, Pacitti held several leadership roles at Abbott Vascular, including division vice president of U.S. commercial operations, sales and marketing, where he oversaw the company's North American business and played a pivotal role in key launches, including Abbott Vascular&#8217;s first drug-eluting stent franchise and structural heart franchise. From 2009 to 2013, he served as vice president of commercial operations, and from 2006 to 2009, he was vice president of global marketing. Pacitti joined Abbott Vascular through its acquisition of Guidant Corp, where he held positions of increasing responsibility from 1995 to 2006.</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pacitti serves as chair of the AdvaMed Medical Imaging Technology Division&#8217;s board of directors and on the boards for Orchestra BioMed and the Siemens Foundation. He is also a member of the CEO Council for Growth at the Chamber of Commerce for Greater Philadelphia, the Children&#8217;s Hospital of Philadelphia Corporate Council, the Medical University of South Carolina (MUSC) President&#8217;s Advisory Group, and the NextGen Advisory Board for the University of Missouri. </font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">&#8220;I am honored to lead such a dynamic organization,&#8221; stated Pacitti. &#8220;Avanos has a strong portfolio of market-leading products and is committed to delivering breakthrough medical device solutions that improve quality of life. I look forward to building on our success and driving long-term value for our stakeholders.&#8221;</font></div><div style="margin-top:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pacitti holds a bachelor&#8217;s degree from Villanova University and an MBA from the University of Maryland.</font></div><div style="margin-top:9pt"><font><br></font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-top:6pt"><font><br></font></div></div><div style="margin-top:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">About Avanos Medical</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Avanos Medical (NYSE&#58; AVNS) is a medical technology company focused on delivering clinically superior medical device solutions that will help patients get back to the things that matter. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today&#8217;s most important healthcare needs, including providing a vital lifeline for nutrition to patients from hospital to home, and reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its recognized brands globally and holds leading market positions in multiple product categories. For more information, visit </font><font style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%">www.avanos.com</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:120%"> and follow Avanos Medical on X (&#64;AvanosMedical), LinkedIn and Facebook.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="margin-top:6pt"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>4
<FILENAME>avns-20250314.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:010ac6d6-ca10-4749-8791-fbf067c5aa98,g:27a292ec-0cea-45d2-b08f-f668e2e63864-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:avns="http://www.avanos.com/20250314" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.avanos.com/20250314">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avns-20250314_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="avns-20250314_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="Cover" roleURI="http://www.avanos.com/role/Cover">
        <link:definition>0000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>5
<FILENAME>avns-20250314_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:010ac6d6-ca10-4749-8791-fbf067c5aa98,g:27a292ec-0cea-45d2-b08f-f668e2e63864-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_87d908f5-1b82-4db1-b645-2d5fea544743_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_0e58a818-daf9-4de0-8b45-2193db44a6c8_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_ed0d6826-e32c-4a56-9b13-d6458f83b6b6_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_5c5d2e0d-5a5f-4c09-89ce-5a551f2e7336_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_8e4e20d4-2a93-41de-932f-ab8166261c76_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_3bfa02e4-9f84-4ccd-8696-0a983f4f2ddf_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_de955380-bb72-4d68-bb9f-fcdcaf530ffd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_ad55c66a-d561-4947-81f8-b91af96ef053_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_affd6da5-6e23-4cdb-8de0-c4b1e6e6aeeb_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_875d3d30-3a44-4bfe-9372-ec27322a2ebd_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_085941c5-1608-4482-80e2-4f63cae319f9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine2_de877ccf-e477-4e6b-bfd5-42f2847926bb_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine2_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine2" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Address, Address Line Two</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine2" xlink:to="lab_dei_EntityAddressAddressLine2" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_f725c99a-9075-4fb2-b89d-b62dc19292fd_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_c3faa3d5-d979-457f-8049-0de46b2fb498_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_af0f6c39-7328-426c-9053-0ac29be76df6_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_91cd2998-b6f5-4e12-a31e-25bdd3710f50_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_f0db5439-29d8-4b60-a52c-d2c06ebb46fb_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_a3ff7137-47ed-4dfe-8e64-af7a84c39c3a_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f48a091d-3261-44cc-aaef-fdb3b9700400_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_658adfc3-f260-4959-bdbc-3356269a3b4d_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_6686c5e3-c4a9-4e18-a6ab-a2bffe095f21_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_760a109b-40d8-4907-8ad9-4ec108ef2b99_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_2fc8bdfe-461d-4e62-b334-2499c81df692_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>avns-20250314_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:010ac6d6-ca10-4749-8791-fbf067c5aa98,g:27a292ec-0cea-45d2-b08f-f668e2e63864-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.avanos.com/role/Cover" xlink:type="simple" xlink:href="avns-20250314.xsd#Cover"/>
  <link:presentationLink xlink:role="http://www.avanos.com/role/Cover" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_1c216b0a-5ed6-45d0-b3d0-9ff6a09abdfa" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_DocumentType_1c216b0a-5ed6-45d0-b3d0-9ff6a09abdfa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_bbca3556-2e1d-470b-8b58-6b1551e5332e" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityFileNumber_bbca3556-2e1d-470b-8b58-6b1551e5332e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_fcaf811e-363f-4fe8-9051-1cb90611e717" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityRegistrantName_fcaf811e-363f-4fe8-9051-1cb90611e717" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_a2b18278-44cd-44da-8915-20343d5930ab" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityIncorporationStateCountryCode_a2b18278-44cd-44da-8915-20343d5930ab" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_c3ae08ae-5bc1-4c13-ab9e-ec4ec65497d3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityTaxIdentificationNumber_c3ae08ae-5bc1-4c13-ab9e-ec4ec65497d3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_76e1b719-d247-4f28-9afc-0e1e426811bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityAddressAddressLine1_76e1b719-d247-4f28-9afc-0e1e426811bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine2_6b485aa1-458b-4036-9b14-7ec7b5f930bb" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine2"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityAddressAddressLine2_6b485aa1-458b-4036-9b14-7ec7b5f930bb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_d2813df0-469e-456f-9fbb-51b6cb9ed135" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityAddressStateOrProvince_d2813df0-469e-456f-9fbb-51b6cb9ed135" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_95c693cd-2e0c-4c62-aa3b-eb8a64fce06d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityAddressCityOrTown_95c693cd-2e0c-4c62-aa3b-eb8a64fce06d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_901ca752-596d-4db9-bbc6-66ed55063b4b" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityAddressPostalZipCode_901ca752-596d-4db9-bbc6-66ed55063b4b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_5ee3b6a1-eff8-499c-80e6-5b09f6ad5973" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_LocalPhoneNumber_5ee3b6a1-eff8-499c-80e6-5b09f6ad5973" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_e715ec61-0008-4106-ad9b-3f1b33ead839" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_WrittenCommunications_e715ec61-0008-4106-ad9b-3f1b33ead839" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_0e86a556-ac21-4e98-a74d-2e57e0ab6508" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_SolicitingMaterial_0e86a556-ac21-4e98-a74d-2e57e0ab6508" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_e522c90d-248b-4855-a1a3-cce166cd6c5c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_PreCommencementTenderOffer_e522c90d-248b-4855-a1a3-cce166cd6c5c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_44260e9b-4a8b-4181-8565-c7c4d33feb8c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_44260e9b-4a8b-4181-8565-c7c4d33feb8c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_132d8e8b-b068-4d0d-97ba-e254b2cecccc" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_Security12bTitle_132d8e8b-b068-4d0d-97ba-e254b2cecccc" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cee47196-ce5f-4ef3-b00c-964f648be5c6" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_TradingSymbol_cee47196-ce5f-4ef3-b00c-964f648be5c6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_63bb8aa5-4cf0-4f14-9dbd-d2361d3f52bf" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_SecurityExchangeName_63bb8aa5-4cf0-4f14-9dbd-d2361d3f52bf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_86372843-8290-4e10-8609-34b2bf1e946c" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityEmergingGrowthCompany_86372843-8290-4e10-8609-34b2bf1e946c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0842c5de-3dc5-42b8-a2e5-ee3e61f5754a" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_EntityCentralIndexKey_0842c5de-3dc5-42b8-a2e5-ee3e61f5754a" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_afcb2736-9478-42c3-bc14-17276197148d" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_AmendmentFlag_afcb2736-9478-42c3-bc14-17276197148d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_ee9a7070-ac0c-4b7a-a535-8281b920a7d0" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_DocumentPeriodEndDate_ee9a7070-ac0c-4b7a-a535-8281b920a7d0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_920ebd52-4f6d-4b97-b3f4-94ef870a35c3" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="23" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_61cc061a-1090-4d5f-b4d6-1d45df7246e4" xlink:to="loc_dei_CityAreaCode_920ebd52-4f6d-4b97-b3f4-94ef870a35c3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>avanoslogoa08.jpg
<DESCRIPTION>AVANOS LOGO
<TEXT>
begin 644 avanoslogoa08.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[@ .061O8F4 9      !_^$ AD5X:68
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M 1$  A$! Q$!_\0 'P   @(" P$! 0            H)"P<( P0%!@(!_\0
M6!    8! P(# P0)#0L- 0   0(#! 4&!P 1"!()(1,*,4$442(5%S)"M-26
M5W=X.6%QL7*2LB,S);75%EA2<[,D='6V-Q@X&H'!8H)#4\/C-(0UAD@9_\0
M&0$  P$! 0                ,$ @$%_\0 )!$  @,  @(# 0$! 0$
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MQGJQ9H9?X:5A)ABAU).$%-AZ#IF\0';6;^$S5/+17>?_ -;>Y5_;/SE^%/\
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M)$U#@R]KIP- "O\ ZGOBP.0^-.,^4<!&F<6' EK-5[:X;IJ*+#CC(YTDBJ*
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M RK&2<;-1S"8AY!C+1,HS;2$9*1CM-_'2+!X0%$5T%TC'26353,!B'(80$!
M0';5 D[V@"OX]25RO/FSFLQP/!2BKFD\8*V2MN6J2RGP*N3+@1"0FEN@1\LQ
MV[8&30Q@#P,D<N_MU%O:7'T595A21F]LGBTXYB\WL"X259KNJJ_MS>U9&41
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MS5JA>DF'4=1$IA\T6,H4IG#%0WM+U)B(J)*;6]^]6R;KTLBOEU"5%B[Z<_\
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M9OQ:U<+F.(LW!D8ZR-$2B7I(5)86#DI0-N(J*FV\!'5/KVY0C:OR.$ZJ$!H
M7:]3=^CN@OSA,>_<$UI'L?D;CR5_&HBHME^&7^Z'Q=_-\P]_H_'Z]*G"(;<F
M=;95*W>JQ8:5<82.LE3MD+)URRU^7;%>1<U!S*)V[IJX2-\U1-=%0Q# /N'6
MFI.%:IW=>VQ9>W=R*=Q,,TE)/CWDY>2L6$K@Z 7)4F!% ,[KSU?;87L(*I""
M)O%5$R2H>)CE)Y^N?1_\*\[]D:*83Y&9/P&RRU#4*8\BN9PQ99L0Y,K;SJ7A
MK)5+&D(%,HB!@*#A@OTKM%P^<0W4 #TG.4V:V=3;4F"=9.EB[Z<_]%OBO\HF
M9/Y_=ZNP_))K^B<_3A9@+E/@R)Y,<<<UX"FE"H,LKXXL].2=F$ ".E))L<&+
MK<2*;?"/2I+ /2(_-\/'6;+LH.IPY*G_ "#0[5BZ]7'&UXB74#<:'99JHVB&
M>HG0<QL[7W"C5RD8JA2'#I52-L(@&X;#[]><U!:G(SGZ;KN,UW#=UL'"/,%@
M1A:?EZQDL^%9Z5< C%Q&4W::35U"*JJ& J!9]%%$6N_A\0GY8?/<!JC#2/#$
MZTGR/%:K)PT &@#2SGSS9QCP*XY7'..0W[165;M',/C2EBY!.6R'D)VD<6$:
MU3WZQ(!P\UVJ ;)(E.<?$  <7NJ*35:]G!5N9*R':\MY#N^4;U)'E[ED.USU
MSL\D?< =SEC<J.W)B%$QN@GFJB!" .Q2[%#P ->>W/DL2@:O]+=Q0DY"\9KY
MEV*+61@:]!CA3&CQPB<B,E8)P[:0L#A#K3 IO@6B#-N"A##XK*$';80&CUZ_
M(G:WP.CZK)PT >02P0*DZO5TYN(/9FT4WG7-=))(FG6\([5402>': ?X@B"J
MZ*B9%1)TB8IB@.X"&@#U] !H 0#]25Q/Q7Q[Y9X^R5BN&C*HWY%TV?MERJD,
MV(RBT+S6GR;=[*(MT]B(?2R;M(ZI2% IE2**;=1S#J+>JJY15E:40 8ZM,K1
ML@T6ZP2RK:;I]RK%IAG"!A(LA*U]Z@[;G((>(&*LB40$/?I"<#.1TKU0_+ U
M0PUB/B'6Y$R,QEJ<')N0DFZAB*%HE+.9&,:J]"@ )'\P<5NDY1\6H"&J_8M"
M@GQK\B0FI"D<1X@>H7X2<2.,^&>.]7X[<B73/&-'B(63E"!6$_IRTK%^)F'_
M (2Z8B#R47<*D$Q0'I$H" "&P55W55$$]LG9R;(_\5+Q(_LY<C/W=9_IK7?]
M*^CG\6'_ !4O$C^SER,_=UG^FM'^E?0?Q8MIW=.:_'WGYR'KW(+"6.,B8WFW
MU$CJKDUI?/HP0L$K6E#)QC]L,<\>;G"..5LMY@E^:DETA]D.D:W5W*&YU=5#
M-$>..;;+QNSUB+/%044+/XIOU<N;1%,2%^D&\0X(=TS,)RG)T/FGFMU-P'YI
MQUBKZN3;4J"V)QAD2L9=QQ0\ITJ01E:CD:H5V[5J1;J JB\A+,T2>-C@8-@'
M=)8-_P!77I)R1-0?=:Z<#0 DGZH_BT:M9;PMRY@& %BLEP"V*;\NB4VR5OI@
M&<Q*ZO2F! %[%K*(@8Q]Q^' -M@U)[%8<E&-O@4_U,//VDDHLHFBBF=594Y$
MDDDB"HHJHH.Q2E*&XF$PCL !H M'>U;Q>#B%P1P%B)\S*RMRE41OF0R=)RK?
MU]R!M)OTE04*0X&9>>1IL(> )  > !KT<Z]:I$=WV9(9K9@- "8GJD^6(25F
MPCPSK4EU-ZVU4S7E%NV7'I&7ERK1]=9K 0^W4@T!ZZ.F<OL51.'NU)[%O@HQ
MK\BB: (BLB#DZJ;<54P<'03!58B(B'6)"F,0IC 7?8!, "/O#4P\=5P[ZE/@
M]@_$^-\.T?C/R,8U'&%(K-&K[;JK'66,K+-)HF8XA,AUG4!+K4/MN8PB8?$=
M5KV$E$$SR;,D?\5+Q(_LY<C/W=9_IK1_I7T'\6'_ !4O$C^SER,_=UG^FM'^
ME?0?Q8K)W.^3F#>8_+6X<C<$T:\8[B,C0U<>72O7HK$'RM]BVX,G;UN+!Z]1
M\IXV;MSF 3%'S.LVWSM3Z65W*'43JH9\#V^^3;[A]S%P-G]!9P2(IEX8-[JU
M;J@D,ECZQ@:-G&X]7S!$T8Z6,GU ( <"F]I0T4MT<G;+LH+52*E(Z<C(Z:AW
MK:2B9=@SE(N19*@X9R$=()E50724*(E.15(Y3%,'@(" Z]$B._H 7:]3=^CN
M@OSA,>_<$UI'L?D;CR5_&HBHME^&7^Z'Q=_-\P]_H_'Z]*G"(;<FRNM'#4+G
M)PUQCSLXZW3 636Y6Z<RW&4I=M00*M+4"^1Z:GT=+M-]A$4%#B1=+< 51,HD
M(@!]PS>BNH9JMNKDK .2''C*'%3-5]P-F&!5@;SC^:7BWQ-A/'S# ?GLY-@J
M( #AI(MC$7;JA[2&#< ,!BAYUJ]7#+$^WDP?KATL7?3G_HM\5_E$S)_/[O5V
M'Y)-?T3GZ<+#0 GKZB3M4S4W(2_< X_UL\D<D<W#DM38-CU/2H1*144;DW01
M+NJ5-LF5*6V 1*4I'([E\\Y9=\__ *0_*_PQ.!)51%1-9%0Z2R1R*I*I'%-1
M)1,=RF*8-A*)1#<!#4I0,\=OOU)&6L$UZ#Q5S!JDSGZBPK=".A<H04@DWS%"
MQR =*:4@5X8C.Q%3* %*JJLBN ;B=58=@"C/?KX8FV4\$_%:]0UVN+!&?2#K
M,MNJS@J(*JQ%DQ1/)221A#?HW9LWK90P>S^#6,'ZNGK>HK^5C4?DEZGSB;1X
M-ZTXTX\R!G.YJME C)"SQQL:8^8N1$"E.Y4=>9,. * B;RDV9.K;I\PF^X8M
M["7!I8M\B?/,?FYR&YV925RKR"N1YV0:HK,*I58I(T71Z%"K& PLH:.ZU"-B
M'$I155.8ZJH@!E5#B "$M[N[ECZU5> X5<,LQ\Z\[UC!F'8@ZSR262?6^W.V
MZAJUCJFHJ$*\F)18@"!$T"FV23 >M902I)@)S!HI1W<(+6ZJ2SWXM<;<<<1L
M"XXX^8JCP9U''<$E&INU$2)2-AF5S&6D)5Z) V.YDWJBCA8?8 FZ2[% H!Z%
M:]5"(V^SDV UHX1I]SON48Q[;V$2W2PMDK;EJ\%E8G"^,"JF1-:9Z/(F*SQ^
MJ3YS6-BQ72.[5 >HW45)/YYP$J]-/YHW2G=E>VS[BW,..Y92/-=CF6P-L_2T
MFHYDI\@E/!O8%02@$ K%'ZF*D0FBF1%./,04RE*42@"A2G"+^CF?DJZ*(&KN
M*7J@\!VR$C87EYC&U8FN:#4J<E<\:L#WC'4JY2 H&6*Q%7Z;C?-$1,"(%<@7
M_O1U37V$^1%L7\&[5\]1'VQ*A6',["92NF198K)9PPJ-0QE,(34@Y(03$0%6
M5;QK!L)S;%ZEER@'MUI[U1E9,27[D7/F]]Q/D=*9LM<02HUF+B6].QE04'YI
M%"H4J.5663(LL($(X=O%UU%W:Q2% 3"!"AT$( 2:7_HY**5Z*#I=M#BY8.7_
M #7P1A^(CU7D(-SB+ID5V"(JM8C&M*<HOI=9<0\$P713!HD8?#S54P\=]M&=
M>S2"[ZHSAW4[_FOF7SGSCF&/Q?E)]26M@-C[&!BT*4.W#'E"$[!BLB(,B#T2
M*A%G^Q@W 5A ?'7=6[6;.475$>'U'YJ_%!E'\ );[TUB#<A]1^:OQ091_ "6
M^]-$!(?4?FK\4&4?P EOO31 2'U'YJ_%!E'\ );[TT0$A]1^:OQ091_ "6^]
M-$!(?4?FK\4&4?P EOO31 2/I>G.SK>+OPODL!Y/KUN@+=QMM2D%!&MD$[AE
M)/&=T%>1B@0,[(F9?Z/=E>MC%*&R:94 ^V#5N%I4$VJ\C!6G"@T 1N=VSBN/
M+_@3G;%T9'#)7>$KXY.QFBDF99V>^8\ []LW;E*("962:E<,"[^'\/XZ7K7M
M5HW1]65HWU'YI'Q#$&4!_P#H$M]Z:@AE<DD?:3X)Y!Y$<]L$U6_XRN,3C:GV
M ,JY#=6:IOHJ'7K./!(^*R54<HHD,$G(%:LA*4V^RHB ; .V\J=K&+VA%ESK
MT"0- 'ESDS'5R%E[#+KF;1,%%R$S*.2(*.CMXZ+2.NN<$DBG54$B1#"!2%$P
M^P $?#0!5K\TK#R Y=\I<V\BI;$V55"9,O$G+0""E%F%PC::SZ6D(S(8S,#=
M+2);MTB[A]KKSKMV<EM5U4&K_P!1^:OQ091_ "6^]-9@[(?4?FK\4&4?P EO
MO31 2'U'YJ_%!E'\ );[TT0$A]1^:OQ091_ "6^]-$!(?4?FK\4&4?P EOO3
M1 2'U'YJ_%!E'\ );[TT0$EBCV,.0-NS=P$QW6LDQ5GA\D8"74PM8T+9$/HJ
M2?0U<115@78"^3(=<IX5=NB)RB(=29@]H:NQMVJ2Z*&3%Z:+%]?4GUJQVKM^
M0<95Z_.622#/V/W Q\!$N)EZ5 C&9 R@I-DU#@4!, "80VW$ ]^D>Q^1N7(A
M:.$,T@ B.(<H   (B(T"6   /_::C@IDM3N'C5TQXF<963ULX9/&F \1MG;-
MX@=JZ:N4(%@4Z:B:@%.F8A@$#%, " ^ Z]&G"(K<FQVM' T 0/=\GM;-><V%
M!R]B:"3-RDPK#/'-9(T J+C*5%0ZW#RMK^SS7"9NIQ%G,/@J)T? JXF(G;/N
MI7(W._40&-@W-A#&(?#V4BG(8Q#D-CZ6*8AR#L(" M-P$!#80U%!3)80^GJ@
M9VM=L?&$38X27K\JAD++ZBT9.1B\2_336G71B&%%P1-0 .4=P';8=6X**DNO
M)-SIPL- '&LBDX2507237073.BLBL0%$EDE $IBF*8! P& =A ?;H 5'[EWI
MPZ[E*8L&:>"+NO8\M\HLO*V' 4\J$1CZ:?JB8ZJM<>E*8D&HL8=P9+%^&W$>
MA1N0 (,VF$^:CJ:QX8H?GGBGR0XP3RU<S]A;(6+)!)Q\*DO:*\LW@Y%7;?\
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E\# _Y\;?X74M.2E\%F'@G_5/2?\ ,;#_  1->@B-\F7-=.'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>avns-20250314_g1.jpg
<TEXT>
begin 644 avns-20250314_g1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_[@ .061O8F4 9      !_^$ AD5X:68
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M 1$  A$! Q$!_\0 'P   @(" P$! 0            H)"P<( P0%!@(!_\0
M6!    8! P(# P0)#0L- 0   0(#! 4&!P 1"!()(1,*,4$442(5%S)"M-26
M5W=X.6%QL7*2LB,S);75%EA2<[,D='6V-Q@X&H'!8H)#4\/C-(0UAD@9_\0
M&0$  P$! 0                ,$ @$%_\0 )!$  @,  @(# 0$! 0$
M  $1 @,Q$B$$05$R$Q1A(D+_V@ , P$  A$#$0 _ '^- !H U:YL\D(;B/Q4
MSCR&F#(&'&]$E9&!9N%@0++W&0 K*$8@82F !>2SENC[!^RWUF]NJDU5=G!7
M'*=W#N5JJJK&YG9O ZRRJYP3LI44P.L83"!2$1*0A0$?FE*   >     :@_I
M;[*NB^B;;L,]UOD1D+F0M@'E-G&XY2K^:J?(1N/5[U+IO/ZNY(JP'D6Z;=0Y
M2"0)./([0,F7Q.J"/R>+L=&W#%Z424H=@U63AH - "&7>1Y5]Q3A;SPRGCVF
M\M,W0.*[J6/ROBB-;682Q\74KEY@JQS</*$")1<J@[:(DW$02(F)O$=QBUM:
MMN2G-*RX/A^U-WA.5[/G1A.L\F.160,DX@RA,FQ7/1=XFQD(B&EKKTMH>2(0
M$P AV\M\.F901V*F=01\-&>KGRSM\U'@L!=6DH: #0!I1W%.433AQPSSOGT7
M*"$_5J<ZC*&BON(/LBVDQ8V#2 I=S& )!RFHIL'@0IC#X .L7MT4FJ+LX*[P
M.[9W*@__ &?G+WCXVK<?']=+4/\ 2WV5=%]#G7I_[#RDRQQ.L_(GE#F;(>57
M^6KV[8XS9WB7&1;P-%H?FL5'35,4TQ2/)RQW95!\0,1%(P>T=Z\):ED^L)PB
M>#3A8: (\.ZERR/PPX-YLS+$R 1U[6A"T+%JP;^>3(MYZF3!='8I@ZXY,RS\
M.H.G^!'?PUC2W12;I7LROT#NV=RH/#_;/SE_RVG?_P +4/\ 2WV4]%]#%/IX
M>YSG'.V;,L\;N3N7;/E*:M55;Y!Q1-760&0E&+^I&\F8BT%C&*4".&;A)T1(
MI-]T5#;^(Z?AH[.&*UHDI0WCJH0&@ T &@"#CU >?<T<<>#L-?\ !62;3BVY
MK9NH\$M8ZB_^CI16&?,Y519L93I,/EJ'1(8P>_8-)W;JO S)2_(EQ']WGN6Q
MT@PD4^9.:'"D>^:/TV[ZP$>L'"C-0JA4UT%$1373.)=E$S@)3%W*8! 1#4G]
M;?91T7T/[=L3N"TCN(\;(7*425E"9-K LZOFJA(+=2E4NR:6_GH%$PJ"QEB$
M,X8J&^UZDQ$5$C[6YW[J2:]>C)&-,,!H TI[CM[N.,."7*S(6/K%)U&[4_"]
MQGJQ9H9?X:5A)ABAU).$%-AZ#IF\0';6;^$S5/+17>?_ -;>Y5_;/SE^%/\
MY6H/Z6^RKHOH>9[%^:<KY_[=^.\EYIOUCR5?92\Y38/[7:GOTA,.F43-.$&R
M1U1 HB5%(H%( ^P/#5F-G:ODFT4/P3 ::8#0 : (%.Y-WZ>/?":2G,38HCVG
M(/D/%F58RT!%2P-,=X[DB@("G.RJ(*'7<HFVZX]F G#Q*JJ@8  4Z;*GA<C:
M9.PG_P DN\CW$.3SU]_6SD-:Z#67:@F2HN%W2N+JPT1$!#R1/&JDDWA! =A!
MX\5W]^I;:VM\CUFD1O2]LM5A>'D9^S6"<D%#"91_+S+F2>*&-XB)E5E#G$1_
M5'2YDU!F#%G*[DWA"1:2F(N0&8,>.62J:R256R%*1<<J*?B!5V9'/PCDGRIK
M)&*/O#759KAG'5,8-X1>IDSSCF2AZ=S1K+7.%",HV9N<E5&-:UG+,&@8P =P
MNU2^&AYHJ9!W\H$VZ@[;^:8?#3Z>PUR+MBGP.:<?.1.&>4V+J_F3!%[AL@4"
MQIF!M*Q2HE<QT@B!1782#50".8]VV$P LV<$*<NX#MTB41KK964HG:Z\F:]=
M.!H - $&7=C[U6-^WNDIB7',/%Y8Y12L8@_2JCUX=*G8TCI%/K;/[$HW,5PJ
MHL42J-XU$Y%%"#UG41()!43KKT\?(RF?<25Y&]SOG7RGEG[[*_([(HP[U9<Z
M5&I<XM0: Q;K#N"!(F).U;KE3#P*=R"BFWM.([CJ2VCMRRA4532%.P3Z3SZ1
M2FY=*0\SS?CDY)8CSS?;U>:!P/OO[]]8-&Z. NY?SLXT2K.0Q1R;RFR8M%$!
M&J6BR+7RD.44# 84CP\T+Y@0IP#I,9),I]O88!V$-UT=>&<=$_@<M[//>QG>
MX':G. \N8<>5W,\!4WMJ<Y QTU5>8KFH6(%%)9600<*J.J^NJLL0B1!5625,
M.Q3ICTD&K+7OX9/IGU\C"^GB@T *%>J2Y9 PKN$N&-:DT_B)]T;-N4&S=4AU
M$XR+,O'UQHMT'ZR LY%ZY.D<NP^6B</8&I?8M\#\:_(F1J4H,A8ER9:,,90Q
M[ENE/5H^VXUN5=NU>=H+&;G3E:VZ2=I )R^(%.9+I-\H"(:ZG'DXU);&8 S)
M6.0V$<4YQIJQ5JUE6AUJ[Q8!U=34D\U364;' Y2F [58QT5 $ $#%$->E5]E
M)$U#@R]KIP- "O\ ZGOBP.0^-.,^4<!&F<6' EK-5[:X;IJ*+#CC(YTDBJ*
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M RK&2<;-1S"8AY!C+1,HS;2$9*1CM-_'2+!X0%$5T%TC'26353,!B'(80$!
M0';5 D[V@"OX]25RO/FSFLQP/!2BKFD\8*V2MN6J2RGP*N3+@1"0FEN@1\LQ
MV[8&30Q@#P,D<N_MU%O:7'T595A21F]LGBTXYB\WL"X259KNJJ_MS>U9&41
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MS5JA>DF'4=1$IA\T6,H4IG#%0WM+U)B(J)*;6]^]6R;KTLBOEU"5%B[Z<_\
M1;XK_*)F3^?W>KL/R2:_HG/TX603>HUISJT=L/(,JT167-1,EXHMK@B*9E#%
M9*2A8I4X@4!V*F$F!S"/@  (CX:3NO\ R,R?DKK-0E99_P#9WR3#Y1[:'$";
MAW)7)8#$D/CJ3 !W.A-XS.K NR'#V@/FL!-X^T! ?8(:]#)S5$>BALDMTPP&
M@ T &@"N4]0]D>&R!W/,I,85?XDF-J3C;'$DH!1 A9F-CPD'*8#[#>4I)^6(
MA[P$/: AJ'=S8JR4(Q!V.::]NO=(XHM&:)E"0-HM%R>J 03$;,JE 2KT3G'V
M% 3I%( C]L8 ]^N8J;([I^6696KR0- '"X;H.T%VKI!%RU<HJ-W+9PF59!P@
ML42G(<A@$IRG*(@("&PAH @QYB^GUX+<H'$Q:Z+"R7&;)LF9=T>P8G;HEI+^
M15ZS>8^JZW3'& RA^H_P)VIS#]D<=)O@K?\ !E=7458YI]A;G'Q#CYBZ0]>C
M^0^)XDJKIW=L1(+O9V'CDP,85Y2N*E&4:E(F03*J-@<(IAXF5 /'4U\;5'5U
M5B$X0$!$!#80\! ? 0$-*&C/OI[>Z+<<3YCJ_"+,=F=S6%LKOAA<1/)R0\PV
M+<D.=S-6#958VY(^=. MP; .Q')DC)@7S%>JC#2'#$ZTE2.<\GL[5KC'QZS%
MGZVJIDA,54&?MAT%%01&4DV2(ECV!#" @"DC('0:I;_;G+JJUNJDG2EP5.U^
MN]CR9>KED:X/AD[9?;3/W*RR EZ/C9ZS.E7CM4"[CT@==8P@7?P#PUYS<EJ4
M#CWI;>*(PU(S;S(L<6!'MS?DPQC-XX3(*@5JOG1?3[E P'$X$=R/PK<>HH?.
M;&VU5Z]?D1M;X&X=4B#Y>[TZOY#IMKH-L8)2E7NM<FJK88Y8I3IOH6?;*-7*
M0@8IB_/15, ;@.N-2"\%3]RNP#8>+?([,O'^SD5^DL77V>K*#M4ABA+0C=83
MQSX@G(F)B/H\Z*Y3 4 $#>'AKSK5ZN"VKE2,,>E]Y7#1L]Y5XEV*1.2 S77@
MOM$;K*"*#?(M!3-\8BF!C@4@R,(<YSB!1$PMDPT[U[0X%;5GR/(ZL)PT >)9
MJY"W&MV"HV6/;RU=M,)+5R?BG9/,:R<+.(*-73=4OVQ%D%3$,'R#HY#@J?N7
M_'Z9XK<GLX<?)P%!<XNR%.5^/<+"4RLE65#@ZAWANGYH"^B7#9QL'LZ]M>;:
MO5P6U?922 ]F#N(17;\S5F"<NJZQL>9'PC<6SF.22%7XO)-%:.9:K%\ -TB\
M=%7CBCML!G)1,(%*(ZWE?HS.E.Q$K=[C/Y$N=NO]K>C(VB\6:>M]DD!+T"^G
MK(Z5>.UMO';S'"QS;>[?2VY-KP-7>EKXM%G<B9RY?V"-358T2);X;QRZ6*!Q
M):;.5-_.N4P$-R':QA6K<IRCXE<J%_7H]>O+$[/X'5]5DX: -).XQRC9\..&
M6=L\&=)M[#7::]A\?I'4\L[S(]J_DZ$(7^#5W\M\X(L<!+MT$-OMK%[=$V:H
MNS@JN'[YW)OGDE(.%7;^0=.'SYVN;K6=.W9Q454./O,<YA$1^77G%H^5Z9CB
MD&*N)-PY*V&+*WM?)"UJMZVY7;D^*2Q=CQ1=DV,13^,(5],&?',0? 2II&\=
MPVL]>L*2;:TN!EC5 DPQR*PI5^1V"<M8)N2":U=RK0[%3'JBB0+&8+2[<Y&S
MU,IO#S6#KRW*(^XY"C[M<LNR@ZG#DJ<<F8]LV),BWO%MT9#'VW'5NL5*LC/Y
MW0A-5EVJS< 03%*)B"JB(D-M\XNPAX#KS6H+4Y&[/2U\L!79YQX9663$5& I
M9OQ:U<+F.(LW!D8ZR-$2B7I(5)86#DI0-N(J*FV\!'5/KVY0C:OR.$ZJ$!H
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MA1N0 (,VF$^:CJ:QX8H?GGBGR0XP3RU<S]A;(6+)!)Q\*DO:*\LW@Y%7;?\
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E\# _Y\;?X74M.2E\%F'@G_5/2?\ ,;#_  1->@B-\F7-=.'_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Mar. 14, 2025</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-36440<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">AVANOS MEDICAL, INC.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">46-4987888<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">5405 Windward Parkway<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine2', window );">Entity Address, Address Line Two</a></td>
<td class="text">Suite 100 South<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">GA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Alpharetta,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">30004<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">428-2667<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock - $0.01 Par Value<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">AVNS<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001606498<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Mar. 14,  2025<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">844<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 2 such as Street or Suite number</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>11
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
M4$L#!!0    ( "4\<5I&QTU(E0   ,T    0    9&]C4')O<',O87!P+GAM
M;$W/30O", P&X+]2=K>9BAZD#D0]BIZ\SRYUA;8I;83Z[^T$/VYY><@;HBZ)
M(B:VF$7Q+N1M,S+'#4#6(_H^R\JABJ'D>ZXQW8&,L1H/I!\> \.B;=> A3$,
M.,SBM[#IU"Y&9W7/ED)WLCI1)L/B6#0ZL2<?J]P<"A#G>B4^BQ-+.9<K!?^+
M4\L54Y[FRF_\9 6_![H74$L#!!0    ( "4\<5K-7G&E[0   "L"   1
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M$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#!!0    ( "4\<5J7BKL<P
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MCEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#!!0    ( "4\<5HD'INBK0
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M;V-0<F]P<R]A<' N>&UL4$L! A0#%     @ )3QQ6LU><:7M    *P(  !$
M             ( !PP   &1O8U!R;W!S+V-O<F4N>&UL4$L! A0#%     @
M)3QQ6IE<G",0!@  G"<  !,              ( !WP$  'AL+W1H96UE+W1H
M96UE,2YX;6Q02P$"% ,4    "  E/'%:H,!!N5X$   <$0  &
M    @($@"   >&PO=V]R:W-H965T<R]S:&5E=#$N>&UL4$L! A0#%     @
M)3QQ6I^@&_"Q @  X@P   T              ( !M P  'AL+W-T>6QE<RYX
M;6Q02P$"% ,4    "  E/'%:EXJ[',     3 @  "P              @ &0
M#P  7W)E;',O+G)E;'-02P$"% ,4    "  E/'%:JL0B%C,!   B @  #P
M            @ %Y$   >&PO=V]R:V)O;VLN>&UL4$L! A0#%     @ )3QQ
M6B0>FZ*M    ^ $  !H              ( !V1$  'AL+U]R96QS+W=O<FMB
M;V]K+GAM;"YR96QS4$L! A0#%     @ )3QQ6F60>9(9 0  SP,  !,
M         ( !OA(  %M#;VYT96YT7U1Y<&5S72YX;6Q02P4&      D "0 ^
) @  "!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>15
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="avns-20250314.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.avanos.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="avns-20250314.htm">avns-20250314.htm</File>
    <File>avns-20250314.xsd</File>
    <File>avns-20250314_lab.xml</File>
    <File>avns-20250314_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>avns-20250314_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="24">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "avns-20250314.htm": {
   "nsprefix": "avns",
   "nsuri": "http://www.avanos.com/20250314",
   "dts": {
    "inline": {
     "local": [
      "avns-20250314.htm"
     ]
    },
    "schema": {
     "local": [
      "avns-20250314.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "avns-20250314_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "avns-20250314_pre.xml"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 24,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 24
   },
   "report": {
    "R1": {
     "role": "http://www.avanos.com/role/Cover",
     "longName": "0000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "avns-20250314.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "avns-20250314.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line Two",
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.avanos.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001606498-25-000057-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001606498-25-000057-xbrl.zip
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M 9>8%$K.X4TF.>7"<>O7UOE%EYR=GG3:K:]%TCEOFSN5G]=0EP>G$PK*'I&
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MZ+FQ5)4)%?C!6 8BQD?A24 W88PAL4@= $41/4A-W>55]YN<&;HTFLC! E,
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M+@OQ--W2L37,RF:W"N,O?TD6/'-XO?<19:D7^5/X,TQ&P?'_ U!+ P04
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M*^KOUN'_V?XYPV&IYX,_4$L#!!0    ( "4\<5IE^ OS>C8  #4[   4
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M@:%AXSW NV>[!W'?B'FOC1B;@02'3Y94&TSVD%^N:3;3T,=7S,*MWCVU@5&
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MVE2M4VS(]Q$K5,&;&$\/12S)>U$=:+1!8Q]OP_\,UJ8Z1"#8"FJ[<NI,1:D
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MQ_45LWO736/NA*LD:7&MG:1Y36K+-E*-_12R-1Y*F)QK4J@TSK?<@J&!:TZ
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M?<1#O[<6N>8';>U3A='91>25QFD6RS^?RG^N>M-JGVI?%*=_(+7]).=]_M
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M2VF&^2WU^*$G^=1YR:G.1=%%MNF-.11#R$LV@"F8U\VD9)N.O) !^2M.+BS
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M61 %+V^2@*_+(LXZT=@9J?:&N ]ZHDY_BS]K/C9(F+Y"V*YJWY0$R!,B0'?
M'O&JGST6PEV%SDX:>XL6YK&,-N=R/;9)DE#Y#1AKQYO++;N%T/A-21)+<S#K
MN<<R\:J,D%4QL&MTCT6'.**VG)<[4+PM(G]Z^($)#WCND<8W-V+LC]NQXT2"
M_I!!@&TKFFWO>+/XH_AA/K%RN;XL&,8;JJS-^P- "Q $&?0(5DN&;*^R>[B
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MWI7,H#.:I<N_PU_R"/G9D3&WD'(P>NKPN\WV<KW(VE''<9WCC-^CD9^#K"L
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M[@ T#3^LA'/$I.?ZW=+_!U!+ P04    "  E/'%:1Z";)$L*   46   %0
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M341M*/,V4YPHHS&B#LX0S-(UT1J"4E0+)W>XG#RR/:RP1;\1,EXNZRO#T5?
MJ_-54V^K- I .(VK(<2(F98QGN04-(;3U$1M,<W*QN4F7UH<!L*$2YRC)'QE
M]_^6RJZ#^J19KZ_JAT2J+2!C"I,E1BBE. !&-;'!."(B<T* #;DPHQAXUNPP
M$"9<\1POYBO3\*FI2E]V9;U\CP%0*FU54,BU[8NVUG.,D,'DQ&:R7_94!M0Z
MK6@^"H6G-H=Q,.&:YT@97QF"\P0]P8"![V;CIM_S2Q\B]J, Q;DW%+LM^TPI
M5XI89@7Q'IC6/FBO_"@8OFY[&!03+G#N2-9IP7':ME>0/A^+E%Q3P.E-VGXL
M+&<D5UH1GWD9A(@8'^\4D2<]& ;*A,N;.Y7XM1<4\%>X*-XQ[B[*KH*""1YR
MP&X[JG$Q# B]R9PEP)5TW(/'OW'+R1<6A^$PX8+F* E?V?T7R?8/,7VZ6[NF
M*CR S)C1Q ,.7D(4. 1,G@WFRQIG/L"4>I3O'YD;YO@)%RQ?+MY$?O1O;_W*
MUDO8;/EBSNMR:Q61OJ^C12:)"2Z0P(5F043%1^YH/&=U& ,3KDJ.EG(2I:>W
M:TA+1/FGU-QT*US<+FU]5^1:9#R7@N2\UP08);FFA@B<Q5QD8*0>MQ3\@_%A
M8$R^+#E>V$GP<8*2)5N=8HAS^S/<%327W*L 1 2/E'.'R1(F2@1 @&9194J.
M>\#N6;/#GK>:?$%RC)BO3,,QQKNACWG?5799V.@=S_K-.-D_\L$]KG@>YSJ6
M\4PSDS&9C]NQ>&1NF/<G7(5\N7BO[/7M$Z+GD,HFO*W#C[:# L#8C&:46-_O
MK[C,$JN$PCDM9\YP:K- 1WG_6;/#*)AP"7*\F*],0[_%=IS WN^C< HN*(Y!
M3K^/XDQ&G(@8[F#\FV?4"N7'[45\;FV8[R=<=GRQ=#MS^9O%$^W.\,#1WL.)
M_J7_)XFCO?\!4$L#!!0    ( "4\<5K-!R_PE D  .PD   <    879N<S S
M,30R,#(U9F]R;3AK7V5X.3DQ+FAT;>U::V_;.!;]OK^"FV+[ &S%=F(G=M("
M:=JFQ?01-'WL?EI0$FUQ0HD:DK+K^?5S+BDI3N*T23!MLXOV0V&;Y'V>>^ZE
ME/W,Y>K)?B9X^N0?^__L=MDSG52Y*!Q+C.!.I*RRLIBQSZFPIZS;K7<=ZG)I
MY"QS;- ;#-EG;4[EG(=U)YT23QHY^YOA^_ZF5[(?ZW3Y9#^5<R;3QQLR'O?3
M).Z/1ML]OCW<C7='\6"'IX-X)^WUACS];W\#1[$]G+%NJ<3CC5P6W4R0_LG.
MH'1["YFZ;-+O]?ZU<7X?-S-L=;J<C$J'M:DN'&PPD!D^!M&7%#CQQ76YDK-B
MDL )87#6\5B)9D.L32I,-]%*\=**2?-A+Y6V5'PYD862A>CZ0WNU';%V3N>3
M(2R>"^-DPE6MQ.L+R[4SX]VHOS4@?QRL=6FCN'8U\JYNNO3RVF <;0VWKESN
M1?TKU[XF=FLG&H\'?[M8;^WP6F(W?21,LZ$&P&CH,XN#R($M>?%X8VNCV5/R
M- 5\)SW6][L:'=?8^@TTR'S&N'*/-_B<%]HJ/=.\MQO]7LX@T23K?S]G^/:@
M_'(;9 Q&.-A6Q0T\.@OBIH?EW<3]=K0U'MT&]\/MJ#^\&H2W!>A.M+M[]>JM
MJVD[&HW&-X']=X#X-;8":K1Y;P482DPOY3&DL";81@;$:C.YU_/_]FBE.^6Y
M5,O)@P\R%Y:]%0OV7N>\>-"QO+!=*XR<AHU6_BE Z-#LOR[JDH$<#Z^ZA +C
MOQ&IY&A)A>.)NW]ON+O'?N/.8!_[K8JE;;G^5S2O$<T#SUN,@@J+.NQ5D42_
M(GB3"!YJ4VJ#X>E0YWE5P"PG=6'OWQMM[X7H1HG.U\7T0H?H?Z?6=JN>\<NZ
M_U?K;C0-_+T%U;]04#L7"VIPF9+805'HJD@@_Z LM2R<OZ_H*7O&YS)EQSR1
MSDG&+3O,I)BRYU]$4CDY%^S=="H38<X/_W=K_-F-!CO#VXP_.#GN76]068_)
MKT&R]KOV!%<N9K5"K)O<WP!</PE"KX]?'KQ__N'#08<=\:C#WG"39*R_T_$W
MV/OWMG?VCM]#F5U((_Q7UL#D^]I[J8=X>W''7M>(V<.W_SEY'F:<@T]O3QYU
M&&<*%VNZH^=U?3B19 7LG"V1RAR97':8TRE?,EY73LI<)AC_1O5(9UD!=Q)?
M1:*M(AVJJ,/$="H2_]-!::1B_>T0S8A=66%K;^0_.KB-C[_#?=O$>2%=AF"B
MD!V"64F;(4P)-T(8)@L?L$S@QI?1;\S"<8T0Y-HZ9@2QA5KB5S.G3"!XI1%6
MIG5H3Z1 E,\8[$2KRL\$[./)09U97J3L)3))^TG900[G$FX[[>F77CV\$<9&
M.(1MTL+$DMQ!CG&(. AF<U;*N7;09#3("^:G1GK+K*/!9"83-C-Z01Y#K2Z%
M\3,*#H@OB5!* "1LD4D<;M!%-B%[IX+"TV&6*P';O,>)Z'@YM@*BC&-38"RX
M!\UO\4O6>..WO8:NXNR7Q&AKO7A$"\6WUE]&@J?@'-V!T$15YQ O<S[S5BD>
MT^2ES1*)Y#/D%70+,R'=\'))K!4"7QL<K+?1W<;K_7N[@T%O[S-*%N%)A:(U
M*F+-%D*AQL7EXJ5X4O$>/G]'B+I )EYB?P]9Q*DCCG ]53PYG8+F.ZAW+DT+
MPW PUMQX:*;($$$?"*S-\JKI<W]GSP(_#KDC3I!%6@%N2_Q44MNS0 F!"=G,
M9(F\T_/!.@\M*N?2(CT VBG*3>;>!)01<IQD&JDBGTE(8Q> %&CJBV-EQBVQ
MTRJT;94@OS:J';[;>3XV4AORD(B)\+VV$N#RH-<?=MIL9T(1E#%;($PK$:;:
MMXP[=A!3XV:?N$TJQ<UJ!2$$(>)4!^=)ZV-T$E$#09TF$I);EK!U]?L KU#"
M D5&),DT3+%\X9-7=Z ']CP1%"RF!\M(C9=R)6^=BB6*&GR2$=N<V7W!I19^
M4VE R*FI9EU!I>XICQR:&@XA &$#N"IQ%04,I&Y6EB/VPN@<$>Z-*1.(])9G
M5J(*LM"NB=0502)%TUK8* CKC;VPQ5HQ,Z5CB&@C&K'51@7E%YQ&?(VN9IFO
M )[\@9XE237).JIDRB&6[J(KF?%0*7789VDC0FH$]\_X84N)7V4L%?I),+T_
M'@]KTT=WG"6;8/E,6<K4>2)+YQSTU_;@5Z%GL ]GT]*SNAA:-%UFO= OPSC@
M5P$YU.P[0P %B[&G4I,6VD9[F@I^@;DK]<"(4,T,?9LKJP'X7.2Q:(TDMCZD
M$0W3%,D]JIG,A=6,-YL/ ^1$O8M>U1AVC(:-ZE=E)GFG/B%5:L291R^U+245
M&&2L;F?M0XM&?Q#01.MC(:FH"1<TS^@*5AUR5*DL.'OXYN/)X2-VW("YU8:8
M2TO-&'Y49:>-REO0]9$HSM:?^D"3+[1\7MD;::VNC+SK4V7=#E\QGK-,%]J$
M#NV[%=J0'RZ7!30G3)L9+^2?'@]GO=CY]VTUC-OV6C<Z]#8( ,0T,-L.0Q2?
MP!?=9DXKC4[!;0&I-!\"*1 8C*'9 :&E?3% <]HP2#-(I<+34CLF(1W GLPA
M%!W]CXJK.BE*3D&5KYC2^I3RMJ#\04%< 7 DGFBH,DW_]<8T,ZB""UW@-6=S
MKJH 8;_7H>MG6E'_^A]IV$T'AM&4GIB#!J"Z+8!4S'"!"%3Z22J%5,[Y*KXI
M+FB&;YX>A$UKX(_I#.?2:['O^&MO.5>.K+X\;=K!Q C%Z39WY>O4^OK?.SO"
M8P^5JX_<[ UL^#]KGTR4?":Z'JA=/@5B)EPM^-)N_-B7P6OC^\,?8,3@W MC
M_*7T_IPJN/!X[N(C"M_LOO)P O6?5%;XMKK"3PD4T0FZ5E>8JF@T_CI-+5!@
M-.&4K 2.T8<LFPE'17E*U$2E14/TK-Z><["BB?RE&\QF\ 5&T,T4'1$7+>?0
M1(\$N)JZ:7/?N$"H/$5[M7Y\LG0/HSY.CUI:!O /"$"@8&R:QU8>(6":3\_-
MM$2RTG_BF ZI21/+4KP]11:5,V&^@][60\\:6=/5L9+!C-!IX4Z5-%?W*ER-
M="FU!%>%NST%RVMNI.5$\UZDK<Q,H#-#(D8?FNB741,$A!\L5\)X8*>:<IJD
MSUT'PK,C.C=#FT.D8HS7T!HF7!5H+Y!F^_#*'UR939&(O%).EDHT/8TE=$O4
M1N+&CHD*>$"3Q49$)P^]U-\?W;>>W$VGW[$:%HM%Q"^]Y?D9=1DN(%HIO;A
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MB1%-M2 <8)V&B'KFSN8W,RWQY)!\)[Y_KAUYQ*?9J#<>" <UW3>!//2HF_0
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M$!V11-"A+HCIQOJN6P_[6M(A+QT)M4LB4B!9(%)B(9H>6Y!)#&*QG"(V892
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MCY#KLB\7=WL]-8N:[NXKNK]-=V&^2Y5$IM+(2O0&R[6RDQD='4LZOH0FZ.Y
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MEQ4  &%V;G,M,C R-3 S,30N>'-D4$L! A0#%     @ )3QQ6F7X"_-Z-@
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9:'1M4$L%!@     '  < U $  "UX      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>avns-20250314_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="avns-20250314.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001606498</identifier>
        </entity>
        <period>
            <startDate>2025-03-14</startDate>
            <endDate>2025-03-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-22">0001606498</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-23">false</dei:AmendmentFlag>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-24">2025-03-14</dei:DocumentPeriodEndDate>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2025-03-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">AVANOS MEDICAL, INC.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-36440</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">46-4987888</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">5405 Windward Parkway</dei:EntityAddressAddressLine1>
    <dei:EntityAddressAddressLine2 contextRef="c-1" id="f-8">Suite 100 South</dei:EntityAddressAddressLine2>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-9">Alpharetta,</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-10">GA</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-11">30004</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-12">844</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-13">428-2667</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-14">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-15">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-17">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-18">Common Stock - $0.01 Par Value</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-19">AVNS</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-20">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-21">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
